4Josh J. Carlson, Sean D. Sullivan. Linking Payment to Health Outcomes: A Taxonomy and Examination of Performance-based Reimbursement Schemes between Heahhcare Payers and Manufacturers[J]. Health Policy, 2010, 96 ( 3 ) : 179-190.
5Jaime Espin, Joan Rovira. Experiences and Impact of European Risk-Sharing Schemes Focusing on Oncology Medicines[R]. Escuela Andsaluza de Salud P6blica, 2011.
6黄伟.我国药品谈判结果实施模式研究[D].沈阳:沈阳药科大学,2012.
7Espin J. Analysis of Diffrences and Commnonalities in Prcing and Reimbursement in Europe[R]. 2007.
8中国药学会药物经济学专业委员会“协议定价”课题组.医保药品协议定价:理论与实践[R].2010.
9Nathalie Grandls. Drug Price Setting And Regulation in France[R]. Institute for Research and Documentation in Health Economics, September 2008.